Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 12 Breast Neoplasms 9 Fatigue 8 Neoplasms 7 Cognitive Dysfunction 3 Colorectal Neoplasms 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Postoperative Bowel Functions 1 Polycystic Ovary Syndrome 1 Parasomnias 1 Obesity 1 Metabolic Syndrome 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Asthenia 1 Arthralgia 1 Adenomatous Polyps 1

Interventions

Colonoscopy 5 Cholecalciferol 3 Aspirin 3 Selenium 2 Narrow Band Imaging 2 Calcium Carbonate 2 alpha-Tocopherol 1 Walking 1 Vitamin E 1 Ursodeoxycholic Acid 1 Rosuvastatin Calcium 1 Restraint, Physical 1 Occult Blood 1 Metformin 1 Folic Acid 1 Fluorescein 1 Erlotinib Hydrochloride 1 Endoscopy 1 Eicosapentaenoic Acid 1 Eflornithine 1 Diarylheptanoids 1 Contraceptive Devices, Female 1 Colonography, Computed Tomographic 1 Clinical Chemistry Tests 1 Celecoxib 1 Calcium 1 Calcitriol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Adenomatous Polyps × Walking × Clear all

NCT01476631 2013-08-05

Step Down Colon Cancer Risk

Washington University School of Medicine

Phase NA Terminated

Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡